Effects of sodium-glucose transporter 2 inhibitors in patients with lupus nephritis: a before-and-after retrospective cohort study
In lupus nephritis the use of SGLT2i was associated with decreases in proteinuria. Beneficial changes in eGFR, haemoglobin and hematocrit trajectories after SGLT2i initiation were observed, independent of the proteinuria response.
Authors
- Juan M. Mejía‐Vilet (ORCID: https://orcid.org/0000-0003-4062-9412)
- Daniela Edith Sánchez-Mejía
- Isabela Ramírez-Mulhern (ORCID: https://orcid.org/0000-0001-9553-0976)
- María Fernanda Zavala-Miranda (ORCID: https://orcid.org/0009-0006-9072-6957)
- Valeria Navarro-Sánchez (ORCID: https://orcid.org/0009-0000-2203-9430)
- Emiliano Rivero-Otamendi
Institutions
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1093/rheumatology/keaf548
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00